West Nile Virus

Military Medicine

Volumn 169, Issue 4, 2004, Pages 261-264

  Brandt, Antonio L ^a   Martyak, Nicholas ^a   Westhoff, John ^a   Kang, Christopher ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; INTERFERON; RIBAVIRIN;

AFRICA; ASIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DEATH; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EUROPE; HUMAN; INFECTION PREVENTION; INFECTION SENSITIVITY; MILITARY MEDICINE; NEUROLOGIC DISEASE; NORTH AMERICA; PATHOPHYSIOLOGY; REVIEW; TRAVEL; VIRUS ENCEPHALITIS; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

EID: 1842853168     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.169.4.261     Document Type: Review

References (51)

1. Smithburn KC, et al: A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 1940; 20: 471-92.
2. Le Guenno B, et al: West Nile: a deadly virus? Lancet 1996; 348: 1315.
3. Tsai TF, et al: West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352: 767-71.
4. Platonov AE, et al: Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis 2001; 7: 128-32.
5. Chowers, MY et al: Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001; 7: 675-8.
6. Nash D, et al: The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344: 1807-14.
7. Weiss D, et al: Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001; 7: 654-8.
8. Centers for Disease Control and Prevention: West Nile virus activity-United States, 2001. MMWR 2001; 51: 497-501.
9. Centers for Disease Control and Prevention: West Nile virus activity-United States, July 31-August 7, 2002, and Louisiana, January 1-August 7, 2002. MMWR 2002; 51: 681-3.
10. White DO, Fenner FJ: Flaviviridae. Medical Virology, pp 433-50. San Diego: Academic Press, 1994.
11. Duebel V, Fiette L, Gounon P, et al: Variations in biological features of West Nile viruses. Ann N Y Acad Sci 2001; 951: 195-206.
12. Centers for Disease Control and Prevention: West Nile virus infection in organ donor and transplant recipients: Georgia and Florida, 2002. MMWR 2002; 51: 790.
13. Centers for Disease Control and Prevention: Investigation of blood transfusion recipients with West Nile virus infections, MMWR 2002; 51: 823.
14. Centers for Disease Control and Prevention: Possible West Nile virus transmission to an infant through breast-feeding: Michigan, 2002. MMWR 2002; 51: 877-8.
15. Weinberger M, Pitlik S, Gandacu D, et al: West Nile fever outbreak, Isreal, 2000: epidemiologic aspects. Emerg Infect Dis 2001; 7: 686-90.
16. West Nile Virus Update Current Case Count. Available at http://www.cdc.gov/od/oc/media/wncount.htm; accessed April 29, 2003.
17. Centers for Disease Control and Prevention: West Nile Virus activity: United States, August 29-September 4, 2002. MMWR 2002; 51: 790-1.
18. Cernescu C, Ruta SM, Tardei G, et al: A high number of severe neurologic clinical forms during an epidemic of West Nile virus infection. Rom J Virol 1997; 48: 13-25.
19. Bin H, Grossman Z, Pokamunski S, et al: West Nile fever in Isreal 1999-2000: from geese to humans. Ann N Y Acad Sci 2001; 951: 127-42.
20. Han L, Popovici F, Alexander JP, et al: Risk factors for West Nile virus infection and meningoencephalitis, Romania 1996. J Infect Dis 1999; 179: 230-3.
21. Motashari F, Bunning M, Kitsutani P, et al: Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358: 261-4.
22. Centers for Disease Control and Prevention: Serosurveys for West Nile virus infection: New York and Connecticut counties, 2000. MMWR 2001; 50: 37-9.
23. Leffkowitz M: On the frequent appearance of an unclear infectious disease. Harefuah 1942; 22: 3-4.
24. Bernkopf H: The isolation of the West Nile virus in Israel. Harefuah 1953; 45: 99-101.
25. Bernkopf H, et al: Isolation of West Nile virus in Israel. J Infect Dis 1953; 93: 207-18.
26. Goldblum N, et al: West Nile fever. The clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases. Am J Hyg 1954; 59: 89-103.
27. Radt P: Clinical observations on patients with West Nile fever during outbreaks of the disease in 1950-1953. Harefuah 1955; 49: 41-4.
28. Marberg K, et al: The natural history of West Nile fever. I. Clinical observations during an epidemic in Israel. Am J Hyg 1956; 64: 259-69.
29. Goldblum N, et al: The natural history of West Nile fever. II. Virological findings and the development of homologous and heterologous antibodies in the West Nile infection in man. Am J Hyg 1957; 66: 363-80.
30. Spigland I, et al: Clinical and laboratory observations in an outbreak of West Nile fever in Israel. Harefuah 1958; 54: 275-81.
31. Katz G, et al: West Nile fever: occurrence in a new endemic site in the Negev. Isr J Med Sci 1989; 25: 39-41.
32. Hindiyeh M, et al: Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel. Emerg Infect Dis 2001; 7: 748-50.
33. Tardel G, et al: Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. J Clin Microbiol 2000; 38: 2232-9.
34. New York Department of Health: West Nile virus surveillance and control: an update for healthcare providers in New York City. City Health Information 2001; 20.
35. Asnis D, et al: The West Nile virus encephalitis in the United States (1999-2000). Ann N Y Acad Sci 2001; 951: 161-71.
36. Briese T, et al: Detection of West Nile virus sequences in cerebrospinal fluid. Lancet 2000; 355: 1614-5.
37. Johnson DJ, et al: Detection of North American West Nile virus in animal tissue by a reverse transcription-nested chain reaction assay. Emerg Infect Dis 2001; 7: 739-41.
38. Asnis DS, et al: The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis 2000; 30: 413.
39. Petersen LR, Martin AA: West Nile virus: a primer for the cllnician. Ann Intern Med 2002; 137: 173-9.
40. Anderson JF, Rahal JJ: Efficacy of interferon α-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002 Jan; 8: 107-8.
41. Shimoni Z, Niven MJ, Pitlick S, Bulvik S: Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 2001; 7: 759.
42. Kanesa Thasan N, et al: Am J Trop Med Hyg 2002; 66: 115-6.
43. Strickland TG: Hunter's Tropical Medicine and Emerging Infectious Diseases, Ed 8, pp 1019-1021. Philadelphia, W.B. Saunders Company, 2000.
44. Miller JR: The control of mosquito-borne diseases in New York City. J Urban Health 2001; 78: 359-66.
45. Fradin MS, Day JF: Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002; 347: 13-8.
46. Luo D, Lu D, et al: Alphamethrin-impregnated bed nets for malaria and mosquito control in China. Trans R Soc Trop Med Hyg 1994; 88: 625-8.
47. Croft AM, Baker D, von Bertele MJ: An evidence-based vector control strategy for military deployments: the British Army experience. Med Trop (Mars) 2001; 61: 91-8.
48. United States Army Medical Department Center and School. Subcourse MD0152: Diseases of Military Importance, Ed 100. Army Correspondence Course Program, 2001.
49. Department of the Army: Army Regulation 40-5: The Army Preventive Medicine Program, 2000.
50. Centers for Disease Control and Prevention on West Nile virus basics. Available at http://www.cdc.gov/ncidod/dvbid/westnile/; accessed April 29, 2003.
51. Food and Drug Administration on West Nile virus and blood safety. Available at http://www.fda.gov/cber/safety/wnvbld.htm; accessed on April 29, 2003.